Family · Pharmaceutical analytical standards
Azelnidipine
A long-acting dihydropyridine calcium channel blocker, developed in Japan and introduced in the early 2000s for high blood pressure: it widens the arteries by blocking calcium entry into the muscle cells of the vessel walls. This family brings together the active ingredient, labelled standards, nitrosamines and other impurities.
Did you know?It lowers blood pressure slowly and gradually: for this reason, unlike many drugs of its class, it hardly speeds up the heartbeat, and in patients the heart rate stays stable or falls slightly.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
